A second-generation pneumococcal conjugate vaccine for prevention of pneumococcal diseases in children.
作者： Carlos G Grijalva , Stephen I Pelton
DOI: 10.1097/MOP.0B013E328341D1F5
关键词: Virology 、 Immunization 、 Pneumococcal conjugate vaccine 、 Immunology 、 Conjugate vaccine 、 Vaccination 、 Pneumococcal disease 、 Pneumococcal infections 、 Medicine
摘要: Purpose A second generation 13 valent pneumococcal conjugate vaccine (PCV13) was licensed and recommended for universal immunization of children through age five years in 2010. Its introduction is intended to address the residual burden diseases that persists a decade after PCV7.
cdc.gov
sci-hub.se 参考文章(35)
Geneviève Deceuninck, Philippe De Wals, Nicole Bouliannne, Gaston De Serres, Effectiveness of pneumococcal conjugate vaccine using a 2+1 infant schedule in Quebec, Canada. Pediatric Infectious Disease Journal. ,vol. 29, pp. 546- 549 ,(2010) , 10.1097/INF.0B013E3181CFFA2A
Adam L Cohen, Lee H Harrison, Monica M Farley, Arthur L Reingold, James Hadler, William Schaffner, Ruth Lynfield, Ann R Thomas, Michael Campsmith, Jianmin Li, Anne Schuchat, Matthew R Moore, Active Bacterial Core Surveillance Team, Prevention of invasive pneumococcal disease among HIV-infected adults in the era of childhood pneumococcal immunization. AIDS. ,vol. 24, pp. 2253- 2262 ,(2010) , 10.1097/QAD.0B013E32833D46FD
Philippe De Wals, Elodie Robin, Elise Fortin, Roseline Thibeault, Manale Ouakki, Monique Douville-Fradet, Pneumonia after implementation of the pneumococcal conjugate vaccine program in the province of Quebec, Canada. Pediatric Infectious Disease Journal. ,vol. 27, pp. 963- 968 ,(2008) , 10.1097/INF.0B013E31817CF76F
BRUCE FIREMAN, STEVEN B. BLACK, HENRY R. SHINEFIELD, JANELLE LEE, EDWIN LEWIS, PAULA RAY, Impact of the pneumococcal conjugate vaccine on otitis media. Pediatric Infectious Disease Journal. ,vol. 22, pp. 10- 16 ,(2003) , 10.1097/00006454-200301000-00006
Philippe De Wals, Michel Carbon, Elodie Sévin, Geneviève Deceuninck, Manale Ouakki, Reduced physician claims for otitis media after implementation of pneumococcal conjugate vaccine program in the province of Quebec, Canada. Pediatric Infectious Disease Journal. ,vol. 28, ,(2009) , 10.1097/INF.0B013E3181BAD212
F. Zhou, A. Shefer, Y. Kong, J. P. Nuorti, Trends in acute otitis media-related health care utilization by privately insured young children in the United States, 1997-2004. Pediatrics. ,vol. 121, pp. 253- 260 ,(2008) , 10.1542/PEDS.2007-0619
Michael E. Pichichero, Janet R. Casey, Emergence of a Multiresistant Serotype 19A Pneumococcal Strain Not Included in the 7-Valent Conjugate Vaccine as an Otopathogen in Children JAMA. ,vol. 298, pp. 1772- 1778 ,(2007) , 10.1001/JAMA.298.15.1772
Andrew Jardine, Robert I. Menzies, Peter B. McIntyre, Reduction in Hospitalizations for Pneumonia Associated With the Introduction of a Pneumococcal Conjugate Vaccination Schedule Without a Booster Dose in Australia Pediatric Infectious Disease Journal. ,vol. 29, pp. 607- 612 ,(2010) , 10.1097/INF.0B013E3181D7D09C
Dorothee M. Kieninger, Kathrin Kueper, Katrin Steul, Christine Juergens, Norbert Ahlers, Sherryl Baker, Kathrin U. Jansen, Carmel Devlin, William C. Gruber, Emilio A. Emini, Daniel A. Scott, Safety, tolerability, and immunologic noninferiority of a 13-valent pneumococcal conjugate vaccine compared to a 7-valent pneumococcal conjugate vaccine given with routine pediatric vaccinations in Germany Vaccine. ,vol. 28, pp. 4192- 4203 ,(2010) , 10.1016/J.VACCINE.2010.04.008
STEVEN BLACK, HENRY SHINEFIELD, BRUCE FIREMAN, EDWIN LEWIS, PAULA RAY, JOHN R. HANSEN, LAURA ELVIN, KATHY M. ENSOR, JILL HACKELL, GEORGE SIBER, FRANK MALINOSKI, DACE MADORE, IH CHANG, ROBERT KOHBERGER, WENDY WATSON, ROBERT AUSTRIAN, KATHY EDWARDS, Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children Pediatric Infectious Disease Journal. ,vol. 19, pp. 187- 195 ,(2000) , 10.1097/00006454-200003000-00003